Medical Cannabiz World Asia Speakers

Entrepreneur and Master Cannabis Cultivator with over 20 years of experience in organic farming who is internationally recognized and awarded for her unique cultivation methodology and exotic strains. She founded C.R.A.F.T., a vertically integrated cannabis company in the United States. She is a Board Member and Master Cultivator for a medical cannabis factory in Greece, Chief Cultivation Officer and advisor for cannabis factories in Denmark and The Netherlands.

Amelia is the Project Director for Twenty21, Europe’s first national medical cannabis registry hosted by Drug Science and Director of Insides Out Ltd. She spent 17 years in Pharmaceutical Sales and more recently roles such as Clinical Advisor around Medical Cannabis and Project Manager for the Reducing Harm from Alcohol Programme.

Kevin Hall has over a combined 2 decades experience in healthcare and cannabinoids and a back ground in business finance. He is regular guest on TV, radio, internet, regularly quoted in magazine/blog articles. He is the CEO of International Cannabis Solutions, an internationally recognized educator in healthcare and cannabinoids. He is also the founder and Executive Director of Chronic Pain Toronto a federal non-profit educating and aiding both healthcare providers and patients navigate through the healthcare system.

Ivan Ross is widely recognized as an industry expert in the field of cannabis for medical and recreational purposes. His experience in this sector dates back to his time with Health Canada when he helped develop the Government of Canada’s position regarding the use, production, distribution and regulation of cannabis for medical purposes. Since that time he has worked as a consultant with H+K Strategies (National Cannabis Practice) were he offered clients counsel and support in investor relations, communications, regulatory review, strategic partnerships, identification and outreach related to market opportunities in other
countries such as the United States, Europe and Australia and government affairs work at the federal, provincial and municipal levels. In the Spring of 2019, Ivan Ross joined Eve & Co. and is leading the company’s government relations and business development efforts. Ivan Ross has also written several articles, appeared in the media (television and radio) regarding the cannabis industry and has been a guest speaker at conferences in Canada, The United States, Uruguay and Mexico.

The company is developing a revolutionary medical device to cure brain aneurysms; a life-threatening disease affecting 1 in 50 persons in a strongly growing market valued over $1 billion. In 2017 it won ‘Best Med-Tech Start-Up’ at the Oxford Bio Network awards, 1st place at the BioTrinity ‘Perfect Pitch’ competition and an award at the ‘European Health Catapult’ finals.

Mike has 28 years of growing international businesses in large corporations & start-ups.

Experienced in strategic planning, execution, team building, gaining regulatory approvals & fundraising including winning a prestigious Horizon 2020 SME instrument grant.

Mike mentors budding entrepreneurs, is a panelist at industry conferences and sits on the ‘Misfit’ organization steering committee. He studied Pre-Clinical Medicine, Physiology & Pharmacology at Southampton University and holds an MBA from Henley Business School, UK

Dr. Ronen Shemesh – PhD. A scientific and business oriented leader and entrepreneur. Holds a PhD in Genetics and Molecular Biology from the Hebrew University of Jerusalem. He has over 20 years of experience in the Pharma-biotech industry, most of them in drug discovery, drug development and Genomics/Proteomics research and development. Ronen’s career includes Director and VP positions in several leading companies including TEVA, Compugen, QBI and Atox Bio, and has published several top tier publications, and as an inventor of several patents on novel mechanisms and new insights in genomic, proteomic and molecular processes leading to several new discoveries and new biologic drugs. He has led a few global and local projects of New Chemical/Biological Entities discovery and repurposing, using machine learning, bioinformatics and computerized methods, as well as vast experience and knowledge in biological processes and wet analysis lab methods.

CEO of TruTrace Technologies, Inc., developer of the first integrated blockchain platform to register and track intellectual property for the global cannabis market. Mr. Galarza has over 8 years of experience in cannabis and enterprise technology, as well as over 7 years as an attorney and nearly a decade in the advertising and mass media industries.

Prof. Dr.-Ing. Sandro Wartzack is full professor at the Friedrich-Alexander University of Erlangen-Nuremberg. After completing his studies in production engineering in 1994, he carried out research as a research assistant in virtual product development and was awarded a doctorate in 2000. In the subsequent industrial activity in the automotive industry, he held various management positions, most recently as head of simulation and knowledge management. In September he returned to the Friedrich-Alexander-University Erlangen-Nuremberg to the Chair of Engineering Design, which he has been heading ever since. His research focuses on the large field of Digital Product Development with emphasis on artificial intelligence in product development, design assistance systems, tolerance simulation and analysis with digital human models. Prof. Wartzack is a member of the board of directors of the Scientific Society for Product Development (WiGeP), a member of the German Academy of Engineering Sciences (ACATECH), and a member of the board of the German Research Foundation (DFG) in the fields of design, machine elements and product development. Furt